There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Apyx Medical (APYX – Research Report) and MiNK Therapeutics (INKT – Research Report) with bullish sentiments.
Apyx Medical (APYX)
In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Apyx Medical, with a price target of $10.00. The company’s shares closed last Thursday at $4.21.
According to TipRanks.com, Knickerbocker is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Apyx Medical with a $7.75 average price target.
See today’s best-performing stocks on TipRanks >>
MiNK Therapeutics (INKT)
In a report released today, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on MiNK Therapeutics, with a price target of $7.00. The company’s shares closed last Thursday at $1.92.
According to TipRanks.com, Mamtani is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Currently, the analyst consensus on MiNK Therapeutics is a Moderate Buy with an average price target of $8.50, a 364.5% upside from current levels. In a report released yesterday, H.C. Wainwright also maintained a Buy rating on the stock with a $10.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on APYX:
